Okamoto; Shosuke

Patent Applications and Registrations

Patent applications and USPTO patent grants for Okamoto; Shosuke.The latest application filed is for "anti-ulcer composition".

Company Profile

0.55.0

Okamoto; Shosuke - Hyogo JP
Okamoto; Shosuke - Kobe JP
Okamoto; Shosuke - Tarumi-ku Kobe-shi JP
Okamoto; Shosuke - BOTH OF JP
Okamoto; Shosuke - Tarumi Kobe JA
Okamoto; Shosuke - Tokyo JA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-ulcer composition Grant 4,954,512 - Oguro , et al. * September 4, 1	1990-09-04
Phenylalanine derivative and proteinase inhibitor Grant 4,895,842 - Okamoto , et al. January 23, 1	1990-01-23
Phenylalanine derivative and proteinase inhibitor Grant 4,873,253 - Okamoto , et al. October 10, 1	1989-10-10
N.sup.2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof Grant 4,258,192 - Okamoto , et al. * March 24, 1	1981-03-24
N.sup.2 -Dansyl-L-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof Grant 4,227,006 - Okamoto , et al. * October 7, 1	1980-10-07
N.sup.2 -Naphthalenesulfonyl-L-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof Grant 4,168,307 - Okamoto , et al. * September 18, 1	1979-09-18
N.sup.2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof Grant 4,140,681 - Okamoto , et al. * February 20, 1	1979-02-20
N.sup.2 -Naphthalenesulfonyl-L-arginine derivatives and the pharmaceutically acceptable acid addition salts thereof Grant 4,139,529 - Okamoto , et al. * February 13, 1	1979-02-13
N.sup.2 -Substituted-L-arginine derivatives and the pharmaceutically acceptable acid addition salts thereof Grant 4,133,880 - Okamoto , et al. January 9, 1	1979-01-09
N.sup.2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof Grant 4,131,673 - Okamoto , et al. * December 26, 1	1978-12-26
N.sup.2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof Grant 4,117,127 - Okamoto , et al. September 26, 1	1978-09-26
N.sup.2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof Grant 4,108,986 - Okamoto , et al. August 22, 1	1978-08-22
N.sup.2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof, and antithrombotic compositions and methods employing them Grant 4,104,392 - Okamoto , et al. August 1, 1	1978-08-01
N.sup.2 -arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof Grant 4,097,472 - Okamoto , et al. * June 27, 1	1978-06-27
N.sup.2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof Grant 4,097,591 - Okamoto , et al. * June 27, 1	1978-06-27
N.sup.2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof Grant 4,093,712 - Okamoto , et al. * June 6, 1	1978-06-06
N.sup.2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof Grant 4,073,914 - Kikumoto , et al. * February 14, 1	1978-02-14
N.sup.2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof Grant 4,073,891 - Okamoto , et al. * February 14, 1	1978-02-14
N.sup.2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof Grant 4,073,913 - Okamoto , et al. * February 14, 1	1978-02-14
N.sup.2 -Alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof Grant 4,069,318 - Okamoto , et al. * January 17, 1	1978-01-17
N.sup.2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof Grant 4,069,317 - Okamoto , et al. * January 17, 1	1978-01-17
N.sup.2 -substituted-L-arginine derivatives and the pharmaceutically acceptable acid addition salts thereof Grant 4,069,323 - Okamoto , et al. * January 17, 1	1978-01-17
N.sup.2 -naphthalenesulfonyl-L-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof Grant 4,066,759 - Okamoto , et al. * January 3, 1	1978-01-03
N.sup.2 -naphthalenesulfonyl-L-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof Grant 4,066,758 - Okamoto , et al. * January 3, 1	1978-01-03
N.sup.2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof Grant 4,055,636 - Okamoto , et al. October 25, 1	1977-10-25
N.sup.2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof Grant 4,055,651 - Okamoto , et al. * October 25, 1	1977-10-25
N.sup.2 -naphthalenesulfonyl-L-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof Grant 4,049,645 - Okamoto , et al. September 20, 1	1977-09-20
N.sup.2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof Grant 4,046,876 - Okamoto , et al. * September 6, 1	1977-09-06
N.sup.2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof Grant 4,036,955 - Okamoto , et al. July 19, 1	1977-07-19
N.sup.2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof Grant 4,018,913 - Okamoto , et al. April 19, 1	1977-04-19
N.sup.2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof Grant 4,018,915 - Okamoto , et al. April 19, 1	1977-04-19
N.sup.2 -dansyl-L-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof Grant 3,978,045 - Okamoto , et al. August 31, 1	1976-08-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.